Success Metrics

Clinical Success Rate
77.8%

Based on 14 completed trials

Completion Rate
78%(14/18)
Active Trials
7(23%)
Results Posted
50%(7 trials)
Terminated
4(13%)

Phase Distribution

Ph phase_1
3
10%
Ph phase_3
1
3%
Ph not_applicable
8
26%
Ph phase_2
3
10%
Ph phase_4
1
3%

Phase Distribution

3

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
3(18.8%)
Phase 2Efficacy & side effects
3(18.8%)
Phase 3Large-scale testing
1(6.3%)
Phase 4Post-market surveillance
1(6.3%)
N/ANon-phased studies
8(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

14 of 20 finished

Non-Completion Rate

30.0%

6 ended early

Currently Active

7

trials recruiting

Total Trials

31

all time

Status Distribution
Active(8)
Completed(14)
Terminated(6)
Other(3)

Detailed Status

Completed14
Recruiting7
Terminated4
unknown3
Withdrawn2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
31
Active
7
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (18.8%)
Phase 23 (18.8%)
Phase 31 (6.3%)
Phase 41 (6.3%)
N/A8 (50.0%)

Trials by Status

terminated413%
unknown310%
withdrawn26%
completed1445%
enrolling_by_invitation13%
recruiting723%

Recent Activity

Clinical Trials (31)

Showing 20 of 31 trialsScroll for more
NCT06019975

FDG-PET in the Diagnosis of Autoimmune Encephalitis

Recruiting
NCT00904410Phase 4

Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET

Completed
NCT05581550Not Applicable

Somatostatin Receptor Imaging in NPC, EBV Related Cancers

Completed
NCT04938362

Cognitive Function and Fatigue After Brain Abscess

Recruiting
NCT07041372

Cerebral Atherosclerosis Research With Positron Emission Tomography

Enrolling By Invitation
NCT00001379Phase 2

Treatment and Natural History Study of Lymphomatoid Granulomatosis

Completed
NCT06919159

Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer

Completed
NCT06833229

Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma

Recruiting
NCT03019757

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

Recruiting
NCT06797661Not Applicable

Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.

Recruiting
NCT02485834Phase 2

FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer

Terminated
NCT06648317

Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions

Recruiting
NCT02492867Not Applicable

A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer

Completed
NCT04840615Phase 1

Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma

Terminated
NCT06167603

Exploring Brain Molecular Imaging and Blood Biomarkers in Subjects With Glucocerebrosidase Mutations: Toward a Precision Medicine Approach to Characterize Parkinson's Disease Clinical Trajectories

Recruiting
NCT02424656

Alterations in the Brain's Connectome After Severe Traumatic Brain Injury

Completed
NCT03949361

Glucocorticoid Long-term Administration: Effect on Cold Induced Energy Expenditure and Resting Metabolic Rate

Completed
NCT01727622

Arterial Spin Labeling (ASL) MRI for Cognitive Decline

Completed
NCT00923273Phase 1

Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer

Terminated
NCT02317250Phase 3

Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II

Withdrawn

Drug Details

Intervention Type
OTHER
Total Trials
31